[
Abstract]
[
Full Text PDF] (in Japanese / 2672KB)
[Members Only And Two Factor Auth.]
J.Jpn. Surg. Soc.. 102(7): 541-545, 2001
Feature topic
REEVALUATION OF THE SURGICAL INDICATIONS FOR NON-SMALL CELL LUNG CANCER BASED ON THE RESULTS OF POSTOPERATIVE TREATMENT
Patients who undergo complete surgical resection for pathological stage I-IIIa non-small cell lung cancer (NSCLC) are candidates for postoperative chemo-and/or radiotherapy. The indications for surgical resection are not a problematic issue, regardless of the results of postoperative therapy. So far there have been no definitively positive results in randomized phase III trials comparing postoperative adjuvant therapy with no further therapy. Therefore clinical trials should be conducted to determine the most appropriate postoperative regimen in NSCLC.
To read the PDF file you will need Adobe Reader installed on your computer.